Editorial Staff

Drug Rebates: How Pharmacy Benefit Managers Manipulate Price & Limit Choice

/0 Comments/in , , , , , /by Editorial Staff
Share on Facebook
Share on Twitter
Share on
LinkedIn
+

Join host Joe Selvaggi and his guest Dr. Bill Smith as they discuss the complex incentive structure between drug manufacturers, health plans, and pharmacy benefit managers. In this episode, they focus on how drug rebates work and how a system intended to optimize value may actually deliver higher costs and fewer choices. Joe and Bill also use this framework to speculate on the price of a COVID-19 vaccine, and who will likely pay for it.

Guest:

Dr. William Smith is Visiting Fellow in Life Sciences at Pioneer Institute. Bill has recently published a working paper entitled, Growing Drug Rebates Hurt Both Consumers and our Healthcare System.  He is here to share with us his findings on how drug rebates work and how they affect which drugs we are prescribed and how much we pay. Bill has spent ten years at Pfizer as Vice President of Public Affairs and Policy, has been President of a medical device company,  and has had senior staff positions with U.S. Congressional House leadership, the White House, and in the Governor’s office in Massachusetts. He earned his PhD at the Catholic University of America and a bachelor’s degree from Georgetown University.

Get new episodes of Hubwonk in your inbox!

Related Content

Learning From California: Policy Lessons From Golden State Exodus

Joe Selvaggi speaks with Tim Anaya of the Pacific Research Institute about his new book, The California Left Coast Survivor’s Guide, exploring insights and lessons on how Massachusetts can stay competitive.

New England Short Circuit: Distorted Incentives Drive Energy Prices Up and Reliability Down

Joe Selvaggi talks with Travis Fisher from the Cato Institute about the rising costs and increasing fragility of the New England power grid, as green capacity incentives distract from neglected infrastructure.

Controlling Drug Prices: Costs and Benefits of Direct Negotiation with Big Pharma

Joe Selvaggi talks with Bill Smith, Director of the Life Sciences Initiative at Pioneer Institute, about the Inflation Reduction Act’s impact on drug pricing negotiations and its potential effects on drug development, consumers, and taxpayers.

Harris’ Tax Vision: Policy & Politics

Joe Selvaggi talks with Tax Foundation Vice President William McBride about the details and potential effects of the tax policy proposed by Kamala Harris's presidential campaign

Digital Privacy Divide: Can Law Enforcement Google Where You’ve Been?

Joe Selvaggi talks with Cato Institute legal fellow Brent Skorup about the split in the court of appeals over the Constitution's 4th Amendment protections concerning law enforcement's search of location tracking data.

Housing Bond Bill: Could Billions Better Bay State Cost of Living

Joe Selvaggi talks with Pioneer's Senior Housing Fellow, Andrew Mikula, about the recently passed $5.2 billion bond bill, discussing its key features and how it might impact the supply and cost of homes in Massachusetts.

Ruinous Red Tape: Epic Cost of Unchecked Federal Rule Making

Joe Selvaggi discusses the emergence of the massive, costly, and rapidly growing register of federal rules and regulations with Competitive Enterprise Institute’s Wayne Crews.

Property Tax Reassessment: Beleaguered Buildings Bear Burden of Boston’s Burgeoning Budget

Joe Selvaggi talks with Marty Walz, the interim president of the Boston Municipal Research Bureau, about more viable, long-term alternatives to Mayor Wu’s property tax classification proposal.

Registering Republican Realignment: GOP Convention Showcases Conservatism’s New Direction

Joe Selvaggi talks with the CATO Institute’s Dr. Norbert Michel about the shift in the Republican vision and policy goals from decades past, as reflected in the nominees and guest speakers at the 2024 GOP Convention.

Candidate Selection Breakdown: Presidential Primary Primacy or Determined Delegate Detour

Joe Selvaggi talks with MIT Professor Charles Stewart III about the political party’s presidential candidate nomination process and what or who ultimately decides who is chosen.

Breaking Down Encampments: Court Finds no Right to Sleep Outdoors

Joe Selvaggi speaks with Manhattan Institute Senior Fellow Dr. Stephen Eide about the Grants Pass v. Johnson Supreme Court decision and its impact on homeless encampments in Boston and across the country.

Underfunding Overdose Alternatives: Price Controls Hinder Search for Non-Addictive Opioids

Joe Selvaggi talks with Pioneer Institute's Director of Healthcare Initiatives, Dr. Bill Smith, about the challenges posed by new regulations and price controls for developing alternatives to addictive opioids.

Unlocking Affordable Housing: Sources and Solutions for Cost Crisis

Joe Selvaggi talks with Pioneer Institute Housing Fellow Andrew Mikula about his research on the causes and cures for our region's highest-in-the-nation housing costs. 

Jawboning Free Speech: State Coercion Finds Limits at Supreme Court

Joe Selvaggi talks with Cato Institute legal scholar Thomas Berry about the effects of the 9-0 Supreme Court decision in NRA v. Vullo on states' ability to use regulation to target disfavored free speech.